Download PDF
Semin Thromb Hemost 2014; 40(02): 214-226
DOI: 10.1055/s-0034-1365839
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

The Influence of Diet and Nutrients on Platelet Function

Bradley J. McEwen
1   Department of Nutrition, National Centre for Clinical Nutrition, Campbelltown, New South Wales, Australia
› Author Affiliations
Further Information

Publication History

Publication Date:
04 February 2014 (online)

    Permissions and Reprints

Abstract

Cardiovascular disease (CVD) is the leading cause of death worldwide. Platelet activation and aggregation play an integral role in hemostasis and thrombosis. Diets and nutrients play a potential role in modifying CVD progression, particularly in platelet function, and have the potential of altering platelet function tests. Diets such as Mediterranean diet, high in omega-3 polyunsaturated fatty acids (PUFA), and vegetarian diets have inverse relationships with CVD. Dark chocolate, foods with low glycemic index, garlic, ginger, omega-3 PUFA, onion, purple grape juice, tomato, and wine all reduce platelet aggregation. Dark chocolate and omega-3 PUFA also reduce P-selectin expression. In addition, dark chocolate reduces PAC-1 binding and platelet microparticle formation. Berries inhibit platelet function (PFA-100). Energy drinks have been shown to increase platelet aggregation and caffeine increases platelet microparticle formation. Therefore, repeat testing of platelet function may be required, not only after exclusion of known antiplatelet medications but also potentially after exclusion of dietary substances/nutrients that could have plausibly affected initial test data.

Keywords

cardiovascular disease - platelet function - nutrients - diet
 

  • References

  • 1 Australian Bureau of Statistics. 3303.0—Causes of Death, Australia, 2010. Canberra, ACT: Australian Government; 2012
    Google Scholar
  • 2 Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: epidemiological update. Eur Heart J 2013; 34 (39) 3028-3034
    CrossrefPubMedGoogle Scholar
  • 3 Stewart RA, North FM, Sharples KJ, Simes RJ, Tonkin AM, White HD ; Long-term Intervention with Pravastatin in Ischaemic Disease Study Investigators. Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study. N Z Med J 2008; 121 (1269) 11-23
    PubMedGoogle Scholar
  • 4 Go AS, Mozaffarian D, Roger VL , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 2013; 127 (1) e6-e245
    CrossrefPubMedGoogle Scholar
  • 5 Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8 (11) 1227-1234
    CrossrefPubMedGoogle Scholar
  • 6 Koenig W. Haemostatic risk factors for cardiovascular diseases. Eur Heart J 1998; 19 (Suppl C): C39-C43
    PubMedGoogle Scholar
  • 7 Roger VL, Go AS, Lloyd-Jones DM , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 2012; 125 (1) e2-e220
    CrossrefPubMedGoogle Scholar
  • 8 Lorenzet R, Napoleone E, Cutrone A, Donati MB. Thrombosis and obesity: cellular bases. Thromb Res 2012; 129 (3) 285-289
    CrossrefPubMedGoogle Scholar
  • 9 Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359 (9) 938-949
    CrossrefPubMedGoogle Scholar
  • 10 Blann AD, Lip GY. Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets. Thromb Res 2001; 101 (4) 321-327
    CrossrefPubMedGoogle Scholar
  • 11 Shantsila E, Lip GY. The role of monocytes in thrombotic disorders. Insights from tissue factor, monocyte-platelet aggregates and novel mechanisms. Thromb Haemost 2009; 102 (5) 916-924
    PubMedGoogle Scholar
  • 12 Michelson AD, Frelinger III AL, Furman MI. Current options in platelet function testing. Am J Cardiol 2006; 98 (10A): 4N-10N
    PubMedGoogle Scholar
  • 13 Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009; 35 (2) 150-157
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010; 48 (5) 579-598
    CrossrefPubMedGoogle Scholar
  • 15 Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009; 35 (2) 158-167
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Born GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929
    PubMedGoogle Scholar
  • 17 Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87 (12) 4925-4936
    PubMedGoogle Scholar
  • 18 Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008; 34 (8) 709-733
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Allman-Farinelli MA, Dawson B. Diet and aging: bearing on thrombosis and hemostasis. Semin Thromb Hemost 2005; 31 (1) 111-117
    Article in Thieme ConnectPubMedGoogle Scholar
  • 20 Zarraga IG, Schwarz ER. Impact of dietary patterns and interventions on cardiovascular health. Circulation 2006; 114 (9) 961-973
    CrossrefPubMedGoogle Scholar
  • 21 Appel LJ, Moore TJ, Obarzanek E , et al; DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336 (16) 1117-1124
    CrossrefPubMedGoogle Scholar
  • 22 Sacks FM, Svetkey LP, Vollmer WM , et al; DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med 2001; 344 (1) 3-10
    CrossrefPubMedGoogle Scholar
  • 23 Trichopoulou A, Bamia C, Trichopoulos D. Mediterranean diet and survival among patients with coronary heart disease in Greece. Arch Intern Med 2005; 165 (8) 929-935
    CrossrefPubMedGoogle Scholar
  • 24 Burr ML, Fehily AM, Gilbert JF , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 1989; 2 (8666): 757-761
    PubMedGoogle Scholar
  • 25 Joshipura KJ, Hu FB, Manson JE , et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001; 134 (12) 1106-1114
    CrossrefPubMedGoogle Scholar
  • 26 Fung TT, Willett WC, Stampfer MJ, Manson JE, Hu FB. Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med 2001; 161 (15) 1857-1862
    CrossrefPubMedGoogle Scholar
  • 27 Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 2000; 72 (4) 912-921
    PubMedGoogle Scholar
  • 28 Ma XY, Liu JP, Song ZY. Glycemic load, glycemic index and risk of cardiovascular diseases: meta-analyses of prospective studies. Atherosclerosis 2012; 223 (2) 491-496
    CrossrefPubMedGoogle Scholar
  • 29 Willett WC, Sacks F, Trichopoulou A , et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 1995; 61 (6, Suppl): 1402S-1406S
    PubMedGoogle Scholar
  • 30 Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348 (26) 2599-2608
    CrossrefPubMedGoogle Scholar
  • 31 de Lorgeril M, Renaud S, Mamelle N , et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343 (8911) 1454-1459
    CrossrefPubMedGoogle Scholar
  • 32 de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99 (6) 779-785
    CrossrefPubMedGoogle Scholar
  • 33 Key TJ, Appleby PN, Rosell MS. Health effects of vegetarian and vegan diets. Proc Nutr Soc 2006; 65 (1) 35-41
    CrossrefPubMedGoogle Scholar
  • 34 Nöthlings U, Schulze MB, Weikert C , et al. Intake of vegetables, legumes, and fruit, and risk for all-cause, cardiovascular, and cancer mortality in a European diabetic population. J Nutr 2008; 138 (4) 775-781
    PubMedGoogle Scholar
  • 35 Fisher M, Levine PH, Weiner B , et al. The effect of vegetarian diets on plasma lipid and platelet levels. Arch Intern Med 1986; 146 (6) 1193-1197
    CrossrefPubMedGoogle Scholar
  • 36 Arts IC, Hollman PC. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 2005; 81 (1, Suppl): 317S-325S
    CrossrefPubMedGoogle Scholar
  • 37 Bucki R, Pastore JJ, Giraud F, Sulpice JC, Janmey PA. Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis. J Thromb Haemost 2003; 1 (8) 1820-1828
    CrossrefPubMedGoogle Scholar
  • 38 Pignatelli P, Pulcinelli FM, Celestini A , et al. The flavonoids quercetin and catechin synergistically inhibit platelet function by antagonizing the intracellular production of hydrogen peroxide. Am J Clin Nutr 2000; 72 (5) 1150-1155
    PubMedGoogle Scholar
  • 39 Guerrero JA, Lozano ML, Castillo J, Benavente-García O, Vicente V, Rivera J. Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor. J Thromb Haemost 2005; 3 (2) 369-376
    CrossrefPubMedGoogle Scholar
  • 40 Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Clin Chim Acta 1995; 235 (2) 207-219
    CrossrefPubMedGoogle Scholar
  • 41 Brand-Miller J, Dickinson S, Barclay A, Allman-Farinelli M. Glycemic index, glycemic load, and thrombogenesis. Semin Thromb Hemost 2009; 35 (1) 111-118
    Article in Thieme ConnectPubMedGoogle Scholar
  • 42 Ahuja KD, Thomas GA, Adams MJ, Ball MJ. Postprandial platelet aggregation: effects of different meals and glycemic index. Eur J Clin Nutr 2012; 66 (6) 722-726
    CrossrefPubMedGoogle Scholar
  • 43 Ahuja KD, Adams MJ, Robertson IK, Ball MJ. Acute effect of a high-carbohydrate low-fat meal on platelet aggregation. Platelets 2009; 20 (8) 606-609
    CrossrefPubMedGoogle Scholar
  • 44 Erlund I, Koli R, Alfthan G , et al. Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol. Am J Clin Nutr 2008; 87 (2) 323-331
    PubMedGoogle Scholar
  • 45 Keen CL. Chocolate: food as medicine/medicine as food. J Am Coll Nutr 2001; 20 (5, Suppl): 436S-439S , discussion 440S–442S
    CrossrefPubMedGoogle Scholar
  • 46 Rein D, Paglieroni TG, Pearson DA , et al. Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 2000; 130 (8S, Suppl): 2120S-2126S
    PubMedGoogle Scholar
  • 47 Pearson DA, Paglieroni TG, Rein D , et al. The effects of flavanol-rich cocoa and aspirin on ex vivo platelet function. Thromb Res 2002; 106 (4–5) 191-197
    CrossrefPubMedGoogle Scholar
  • 48 Flammer AJ, Hermann F, Sudano I , et al. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 2007; 116 (21) 2376-2382
    CrossrefPubMedGoogle Scholar
  • 49 Carnevale R, Loffredo L, Pignatelli P , et al. Dark chocolate inhibits platelet isoprostanes via NOX2 down-regulation in smokers. J Thromb Haemost 2012; 10 (1) 125-132
    CrossrefPubMedGoogle Scholar
  • 50 Hamed MS, Gambert S, Bliden KP , et al. Dark chocolate effect on platelet activity, C-reactive protein and lipid profile: a pilot study. South Med J 2008; 101 (12) 1203-1208
    CrossrefPubMedGoogle Scholar
  • 51 Holt RR, Schramm DD, Keen CL, Lazarus SA, Schmitz HH. Chocolate consumption and platelet function. JAMA 2002; 287 (17) 2212-2213
    CrossrefPubMedGoogle Scholar
  • 52 Montagnana M, Favaloro EJ, Lippi G. Coffee intake and cardiovascular disease: virtue does not take center stage. Semin Thromb Hemost 2012; 38 (2) 164-177
    Article in Thieme ConnectPubMedGoogle Scholar
  • 53 Natella F, Nardini M, Belelli F , et al. Effect of coffee drinking on platelets: inhibition of aggregation and phenols incorporation. Br J Nutr 2008; 100 (6) 1276-1282
    CrossrefPubMedGoogle Scholar
  • 54 Kurtz AM, Leong J, Anand M, Dargush AE, Shah SA. Effects of caffeinated versus decaffeinated energy shots on blood pressure and heart rate in healthy young volunteers. Pharmacotherapy 2013; 33 (8) 779-786
    CrossrefPubMedGoogle Scholar
  • 55 Worthley MI, Prabhu A, De Sciscio P, Schultz C, Sanders P, Willoughby SR. Detrimental effects of energy drink consumption on platelet and endothelial function. Am J Med 2010; 123 (2) 184-187
    CrossrefPubMedGoogle Scholar
  • 56 Khatua TN, Adela R, Banerjee SK. Garlic and cardioprotection: insights into the molecular mechanisms. Can J Physiol Pharmacol 2013; 91 (6) 448-458
    CrossrefPubMedGoogle Scholar
  • 57 Rahman K, Lowe GM. Garlic and cardiovascular disease: a critical review. J Nutr 2006; 136 (3, Suppl): 736S-740S
    PubMedGoogle Scholar
  • 58 Bordia A, Verma SK, Srivastava KC. Effect of garlic on platelet aggregation in humans: a study in healthy subjects and patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1996; 55 (3) 201-205
    CrossrefPubMedGoogle Scholar
  • 59 Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects. Arzneimittelforschung 1993; 43 (2) 119-122
    PubMedGoogle Scholar
  • 60 Wojcikowski K, Myers S, Brooks L. Effects of garlic oil on platelet aggregation: a double-blind placebo-controlled crossover study. Platelets 2007; 18 (1) 29-34
    CrossrefPubMedGoogle Scholar
  • 61 Scharbert G, Kalb ML, Duris M, Marschalek C, Kozek-Langenecker SA. Garlic at dietary doses does not impair platelet function. Anesth Analg 2007; 105 (5) 1214-1218 , table of contents
    CrossrefPubMedGoogle Scholar
  • 62 Ali M, Thomson M. Consumption of a garlic clove a day could be beneficial in preventing thrombosis. Prostaglandins Leukot Essent Fatty Acids 1995; 53 (3) 211-212
    CrossrefPubMedGoogle Scholar
  • 63 Srivastava KC. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism. Biomed Biochim Acta 1984; 43 (8–9) S335-S346
    PubMedGoogle Scholar
  • 64 Srivastava KC. Evidence for the mechanism by which garlic inhibits platelet aggregation. Prostaglandins Leukot Med 1986; 22 (3) 313-321
    CrossrefPubMedGoogle Scholar
  • 65 Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease. Prostaglandins Leukot Essent Fatty Acids 1997; 56 (5) 379-384
    CrossrefPubMedGoogle Scholar
  • 66 Duttaroy AK, Jørgensen A. Effects of kiwi fruit consumption on platelet aggregation and plasma lipids in healthy human volunteers. Platelets 2004; 15 (5) 287-292
    CrossrefPubMedGoogle Scholar
  • 67 Benatti P, Peluso G, Nicolai R, Calvani M. Polyunsaturated fatty acids: biochemical, nutritional and epigenetic properties. J Am Coll Nutr 2004; 23 (4) 281-302
    CrossrefPubMedGoogle Scholar
  • 68 Goodnight Jr SH, Harris WS, Connor WE, Illingworth DR. Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982; 2 (2) 87-113
    CrossrefPubMedGoogle Scholar
  • 69 Din JN, Newby DE, Flapan AD. Omega 3 fatty acids and cardiovascular disease—fishing for a natural treatment. BMJ 2004; 328 (7430) 30-35
    CrossrefPubMedGoogle Scholar
  • 70 Mozaffarian D, Ascherio A, Hu FB , et al. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 2005; 111 (2) 157-164
    CrossrefPubMedGoogle Scholar
  • 71 Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006; 52 (12) 2265-2272
    CrossrefPubMedGoogle Scholar
  • 72 Jung UJ, Torrejon C, Tighe AP, Deckelbaum RJ. n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr 2008; 87 (6) 2003S-2009S
    PubMedGoogle Scholar
  • 73 Din JN, Harding SA, Valerio CJ , et al. Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. Atherosclerosis 2008; 197 (1) 290-296
    CrossrefPubMedGoogle Scholar
  • 74 Mozaffarian D, Psaty BM, Rimm EB , et al. Fish intake and risk of incident atrial fibrillation. Circulation 2004; 110 (4) 368-373
    CrossrefPubMedGoogle Scholar
  • 75 Grundt H, Nilsen DW, Hetland O, Mansoor MA. Clinical outcome and atherothrombogenic risk profile after prolonged wash-out following long-term treatment with high doses of n-3 PUFAs in patients with an acute myocardial infarction. Clin Nutr 2004; 23 (4) 491-500
    CrossrefPubMedGoogle Scholar
  • 76 Surette ME. The science behind dietary omega-3 fatty acids. CMAJ 2008; 178 (2) 177-180
    CrossrefPubMedGoogle Scholar
  • 77 Vidgren HM, Agren JJ, Schwab U, Rissanen T, Hänninen O, Uusitupa MI. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men. Lipids 1997; 32 (7) 697-705
    CrossrefPubMedGoogle Scholar
  • 78 Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev 2005; 45 (5) 559-579
    CrossrefPubMedGoogle Scholar
  • 79 Wassall SR, Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids 2008; 153 (1) 57-63
    CrossrefPubMedGoogle Scholar
  • 80 Hu FB, Bronner L, Willett WC , et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002; 287 (14) 1815-1821
    CrossrefPubMedGoogle Scholar
  • 81 Hu FB, Cho E, Rexrode KM, Albert CM, Manson JE. Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation 2003; 107 (14) 1852-1857
    CrossrefPubMedGoogle Scholar
  • 82 Dyerberg J, Bang HO. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet 1979; 2 (8140) 433-435
    PubMedGoogle Scholar
  • 83 McEwen BJ, Morel-Kopp MC, Chen W, Tofler GH, Ward CM. Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost 2013; 39 (1) 25-32
    Article in Thieme ConnectPubMedGoogle Scholar
  • 84 Nomura S, Kanazawa S, Fukuhara S. Effects of eicosapentaenoic acid on platelet activation markers and cell adhesion molecules in hyperlipidemic patients with Type 2 diabetes mellitus. J Diabetes Complications 2003; 17 (3) 153-159
    CrossrefPubMedGoogle Scholar
  • 85 Hirai A, Terano T, Hamazaki T , et al. The effects of the oral administration of fish oil concentrate on the release and the metabolism of [14C]arachidonic acid and [14C]eicosapentaenoic acid by human platelets. Thromb Res 1982; 28 (3) 285-298
    CrossrefPubMedGoogle Scholar
  • 86 Axelrod L, Camuso J, Williams E, Kleinman K, Briones E, Schoenfeld D. Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study. Diabetes Care 1994; 17 (1) 37-44
    CrossrefPubMedGoogle Scholar
  • 87 Mori TA, Beilin LJ, Burke V, Morris J, Ritchie J. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 1997; 17 (2) 279-286
    CrossrefPubMedGoogle Scholar
  • 88 Woodman RJ, Mori TA, Burke V , et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis 2003; 166 (1) 85-93
    CrossrefPubMedGoogle Scholar
  • 89 Vanschoonbeek K, Feijge MA, Paquay M , et al. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler Thromb Vasc Biol 2004; 24 (9) 1734-1740
    CrossrefPubMedGoogle Scholar
  • 90 Goodnight Jr SH, Harris WS, Connor WE. The effects of dietary omega 3 fatty acids on platelet composition and function in man: a prospective, controlled study. Blood 1981; 58 (5) 880-885
    PubMedGoogle Scholar
  • 91 Pirich C, Gaszo A, Granegger S, Sinzinger H. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. Thromb Res 1999; 96 (3) 219-227
    CrossrefPubMedGoogle Scholar
  • 92 Agren JJ, Väisänen S, Hänninen O, Muller AD, Hornstra G. Hemostatic factors and platelet aggregation after a fish-enriched diet or fish oil or docosahexaenoic acid supplementation. Prostaglandins Leukot Essent Fatty Acids 1997; 57 (4–5) 419-421
    CrossrefPubMedGoogle Scholar
  • 93 Mori TA, Vandongen R, Mahanian F, Douglas A. Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation. Metabolism 1992; 41 (10) 1059-1067
    CrossrefPubMedGoogle Scholar
  • 94 Thorngren M, Gustafson A. Effects of 11-week increases in dietary eicosapentaenoic acid on bleeding time, lipids, and platelet aggregation. Lancet 1981; 2 (8257) 1190-1193
    PubMedGoogle Scholar
  • 95 Griffiths G, Trueman L, Crowther T, Thomas B, Smith B. Onions—a global benefit to health. Phytother Res 2002; 16 (7) 603-615
    CrossrefPubMedGoogle Scholar
  • 96 Hubbard GP, Wolffram S, de Vos R, Bovy A, Gibbins JM, Lovegrove JA. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study. Br J Nutr 2006; 96 (3) 482-488
    PubMedGoogle Scholar
  • 97 Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2004; 2 (12) 2138-2145
    CrossrefPubMedGoogle Scholar
  • 98 Nakayama H, Tsuge N, Sawada H, Higashi Y. Chronic intake of onion extract containing quercetin improved postprandial endothelial dysfunction in healthy men. J Am Coll Nutr 2013; 32 (3) 160-164
    CrossrefPubMedGoogle Scholar
  • 99 Lippi G, Franchini M, Favaloro EJ, Targher G. Moderate red wine consumption and cardiovascular disease risk: beyond the “French paradox”. Semin Thromb Hemost 2010; 36 (1) 59-70
    Article in Thieme ConnectPubMedGoogle Scholar
  • 100 Tozzi Ciancarelli MG, Di Massimo C, De Amicis D, Ciancarelli I, Carolei A. Moderate consumption of red wine and human platelet responsiveness. Thromb Res 2011; 128 (2) 124-129
    CrossrefPubMedGoogle Scholar
  • 101 Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002; 105 (24) 2836-2844
    CrossrefPubMedGoogle Scholar
  • 102 Bhat KPL, Kosmeder II JW, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal 2001; 3 (6) 1041-1064
    CrossrefPubMedGoogle Scholar
  • 103 Olas B, Wachowicz B, Saluk-Juszczak J, Zieliński T. Effect of resveratrol, a natural polyphenolic compound, on platelet activation induced by endotoxin or thrombin. Thromb Res 2002; 107 (3–4) 141-145
    CrossrefPubMedGoogle Scholar
  • 104 Pace-Asciak CR, Rounova O, Hahn SE, Diamandis EP, Goldberg DM. Wines and grape juices as modulators of platelet aggregation in healthy human subjects. Clin Chim Acta 1996; 246 (1–2) 163-182
    CrossrefPubMedGoogle Scholar
  • 105 Gresele P, Pignatelli P, Guglielmini G , et al. Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. J Nutr 2008; 138 (9) 1602-1608
    PubMedGoogle Scholar
  • 106 Freedman JE, Parker III C, Li L , et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 2001; 103 (23) 2792-2798
    CrossrefPubMedGoogle Scholar
  • 107 Keevil JG, Osman HE, Reed JD, Folts JD. Grape juice, but not orange juice or grapefruit juice, inhibits human platelet aggregation. J Nutr 2000; 130 (1) 53-56
    PubMedGoogle Scholar
  • 108 Renaud SC, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr 1992; 55 (5) 1012-1017
    PubMedGoogle Scholar
  • 109 Zbikowska HM, Olas B, Wachowicz B, Krajewski T. Response of blood platelets to resveratrol. Platelets 1999; 10 (4) 247-252
    CrossrefPubMedGoogle Scholar
  • 110 Das S, Otani H, Maulik N, Das DK. Lycopene, tomatoes, and coronary heart disease. Free Radic Res 2005; 39 (4) 449-455
    CrossrefPubMedGoogle Scholar
  • 111 Dutta-Roy AK, Crosbie L, Gordon MJ. Effects of tomato extract on human platelet aggregation in vitro. Platelets 2001; 12 (4) 218-227
    CrossrefPubMedGoogle Scholar
  • 112 Lazarus SA, Garg ML. Tomato extract inhibits human platelet aggregation in vitro without increasing basal cAMP levels. Int J Food Sci Nutr 2004; 55 (3) 249-256
    CrossrefPubMedGoogle Scholar
  • 113 O'Kennedy N, Crosbie L, van Lieshout M, Broom JI, Webb DJ, Duttaroy AK. Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: a time-course cannulation study in healthy humans. Am J Clin Nutr 2006; 84 (3) 570-579
    PubMedGoogle Scholar
  • 114 O'Kennedy N, Crosbie L, Whelan S , et al. Effects of tomato extract on platelet function: a double-blinded crossover study in healthy humans. Am J Clin Nutr 2006; 84 (3) 561-569
    PubMedGoogle Scholar
  • 115 Lazarus SA, Bowen K, Garg ML. Tomato juice and platelet aggregation in type 2 diabetes. JAMA 2004; 292 (7) 805-806
    CrossrefPubMedGoogle Scholar
  • 116 Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol 2007; 595: 1-75
    PubMedGoogle Scholar
  • 117 Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci 2008; 65 (11) 1631-1652
    CrossrefPubMedGoogle Scholar
  • 118 Shah BH, Nawaz Z, Pertani SA , et al. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol 1999; 58 (7) 1167-1172
    CrossrefPubMedGoogle Scholar
  • 119 Srivastava KC, Bordia A, Verma SK. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. Prostaglandins Leukot Essent Fatty Acids 1995; 52 (4) 223-227
    CrossrefPubMedGoogle Scholar
  • 120 Innes AJ, Kennedy G, McLaren M, Bancroft AJ, Belch JJ. Dark chocolate inhibits platelet aggregation in healthy volunteers. Platelets 2003; 14 (5) 325-327
    CrossrefPubMedGoogle Scholar